AI assistant
Sending…
AtriCure, Inc. — Director's Dealing 2017
Jul 5, 2017
31802_dirs_2017-07-05_015a881f-42ed-4b1f-abcd-c5fb15a36ec5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2017-06-30
Reporting Person: LUX ANDREW L (SVP, Ops & Quality)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-30 | Common Stock | A | 960 | $16.32 | Acquired | 66549 | Direct |
Footnotes
F1: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended June 30, 2017.
F2: Closing price on June 30, 2017 was $24.25.
More from AtriCure, Inc.
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
May 6
Report Publication Announcement
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3